An unbiased, independent panel developed a final report of the 2014 NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain, which summarizes the workshop and identifies future research priorities.
The Annals of Internal Medicine published an abridged version of the final report for the Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain. The abridged version provides a condensed overview of the information and recommendations outlined in the final report.
The program book provides attendees with a workshop overview and agenda, presentation summaries, speaker biographies, and financial disclosures from planners and presenters. The program book also lists working group and panel members, Office of Disease Prevention staff, and educational planners.
Subsequent to the meeting, it came to our attention that the Program Book should have included a financial disclosure for Myra Christopher (Purdue Pharma).
This evidence report is based on research conducted by the Pacific Northwest Evidence-based Practice Center under contract to the Agency for Healthcare Research and Quality (AHRQ). The report seeks to address the identified workshop questions:
The information in this report is intended to help health care decision-makers—patients and clinicians, health system leaders, and policymakers, among others—make well-informed decisions and thereby improve the quality of health care services.